Nadezhdin et al. present structures of human TRPV4 in complex with the GTPase RhoA, in the apo, agonist 4α-PDD and antagonist HC-067047 bound states, uncovering the mechanisms of channel activation, inhibition and disease-causing mutations.
- Kirill D. Nadezhdin
- Irina A. Talyzina
- Alexander I. Sobolevsky